GLP-1 Adoption in Rich Nations Risks Accelerating Ultra-Processed Food Expansion in Low-Income Markets
GLP-1 uptake in wealthy markets may redirect corporate growth strategies toward less-regulated LMIC food environments. The Globalization and Health analysis identifies marketing intensification and retail modernization as primary risks, supported by cross-sector sales and policy data. Coordinated regulatory responses are needed to prevent increased ultra-processed food exposure where obesity is already rising.
Next steps require LMIC governments to implement front-of-pack labeling, digital marketing restrictions, and conflict-of-interest safeguards before 2028, when patent expirations are expected to widen GLP-1 access in middle-income countries. Without coordinated action, the drugs may treat individual patients while entrenching the commercial drivers of population-level obesity.
Even et al.: By 2030, annual ultra-processed food sales volumes in at least five major LMIC urban centers will rise more than 10 percent above 2025 baselines if no new marketing or tax policies are enacted.
Sources (3)
- [1]Primary Source(https://globalizationandhealth.biomedcentral.com/articles/10.1186/s12992-026-01217-9)
- [2]Supporting Source(https://www.thelancet.com/series/commercial-determinants-2024)
- [3]Supporting Source(https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.1234)